AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liener, I. E.
Right arrow Articles by Tarcza, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liener, I. E.
Right arrow Articles by Tarcza, J. C.
Agricola
Right arrow Articles by Liener, I. E.
Right arrow Articles by Tarcza, J. C.

American Journal of Clinical Nutrition, Vol 39, 196-200, Copyright © 1984 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Starch blockers: a potential source of trypsin inhibitors and lectins

IE Liener, DA Donatucci and JC Tarcza

Highly variable levels of amylase, amylase inhibitor, trypsin inhibitor, and lectin activities were found in 10 randomly selected brands of starch blockers. This variability was attributed to the crude nature of the legume protein concentrate used in the formulation of these tablets. In addition to the possible risk to health associated with their trypsin inhibitor and lectin content, the levels of endogenous amylase activity present in such tablets may serve to counteract their alleged effectiveness as inhibitors of starch digestion.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by The American Society for Nutrition